The above studies suggest that the expression level of TPD52L2 in ccRCC is regulated by TPD52L2 methylation and that the methylation level of cg12933587 correlates with patient prognosis and may be a potential prognostic indicator. This evidence concerns the gene TPD52L2 and nonpapillary renal cell carcinoma.